TEMPEST THERAP.
TEMPEST THERAP.
Share · US87978U1088 · TPST (LSSI)
Overview Financial Indicators
7,57 EUR
-3,30 % -0,26 EUR
Lang & Schwarz (XNAS) · Current prices and charts at MoneyPeak
10.06.2025 18:32

Current Prices from TEMPEST THERAP.

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
TPST
USD
10.06.2025 18:32
8,66 USD
8,99 USD
-3,73 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
-3,48 % 28,97 % 31,07 % -23,81 % -32,05 % -79,83 % -98,17 %

Company Profile for TEMPEST THERAP. Share

Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. The company was founded in 2011 and is headquartered in South San Francisco, California. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc.

Company Data

Name TEMPEST THERAP.
Company Tempest Therapeutics, Inc.
Symbol TPST
Website https://www.tempesttx.com
Primary Exchange LSSI Lang & Schwarz
ISIN US87978U1088
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Stephen R. Brady J.D., LLM
Market Capitalization 25 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 7000 Shoreline Court, 94080 South San Francisco
IPO Date 2012-11-12

Stock Splits

Date Split
09.04.2025 1:13

ID Changes

Date From To
28.06.2021 MLND TPST

Ticker Symbols

Name Symbol
Frankfurt 3OS.F
NASDAQ TPST

More Shares

Investors who TEMPEST THERAP. hold also have the following shares in their portfolio:
ADCB FIN.(CAYM.) 2023 MTN
ADCB FIN.(CAYM.) 2023 MTN Bond
DZ BANK      IS.A2190
DZ BANK IS.A2190 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025